INS and diabetes mellitus: The study by Becker et al. which compared tacrolimus/daclizumab and tacrolimus/MMF immunosuppressive treatments stated that not using a steroid decreased de-novo diabetes development and insulin use after transplantation and the patients did not gain weight (21).